Global Huntington's Disease Therapeutics Market 2017-2021

ハンチントン病治療薬の世界市場

◆タイトル:Global Huntington's Disease Therapeutics Market 2017-2021
◆商品コード:IRTNTR14144
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年8月2日
◆ページ数:86
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、ハンチントン病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、ハンチントン病治療薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社はハンチントン病治療薬の世界市場が2017-2021年期間中に年平均14.75%成長すると予測しています。当レポート上に記載されている主な企業は• F. Hoffmann-La Roche• H. Lundbeck• Prana Biotechnology• Teva Pharmaceutical Industries等です。

About Huntington’s Disease Therapeutics
HD is an inherited condition that leads to destruction of nerve cells or neurons. The damage to nerve cells usually causes change in personality, mood swings, irritability and altered behavior. The global HD therapeutics market was witnessing a high unmet demand for disease modifying drug, in the presence of only one approved therapy, Xenazine, and the off-label use of various different therapeutics. The introduction of AUSTEDO in the market will have a significant impact on the market growth, thereby changing the market dynamics.

Technavio’s analysts forecast the global huntington’s disease therapeutics market to grow at a CAGR of 14.75% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global huntington’s disease therapeutics market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off label drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Huntington’s Disease Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• F. Hoffmann-La Roche
• H. Lundbeck
• Prana Biotechnology
• Teva Pharmaceutical Industries

[Other prominent vendors]
• Intellect Neurosciences
• Horizon Pharma
• Sangamo Therapeutics
• Vertex Pharmaceuticals

[Market driver]
• Early onset of disease symptoms, increases the demand for HD therapeutics
• For a full, detailed list, view our report

[Market challenge]
• Increase in alternative programs for management of mental disorders
• For a full, detailed list, view our report

[Market trend]
• Advances in biomedical sciences
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: HD: An introduction

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Pipeline

PART 08: Market segmentation by drug-class
• Market scenario by drug-class
• Antidopaminergics
• Anticonvulsants
• Antipsychotics
• Antidepressants
• Others

PART 09: Geographical segmentation
• Market segmentation by geography
• HD therapeutics market in Americas
• HD therapeutics market in EMEA
• HD therapeutics market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Advances in biomedical sciences
• Focus on regenerative therapies for mental disorders
• Rising public interest toward mental health

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• F. Hoffmann-La Roche
• H. Lundbeck
• Prana Biotechnology
• Teva Pharmaceutical Industries
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits] 
Exhibit 01: Parts of brain affected by HD
Exhibit 02: Key facts about HD
Exhibit 03: Prevalence and incidence of HD
Exhibit 04: Neurotransmitter involved in pathogenesis of HD
Exhibit 05: Market snapshot
Exhibit 06: Global HD therapeutics market 2016-2021 ($ millions)
Exhibit 07: Opportunity analysis of global HD therapeutics market
Exhibit 08: Five forces analysis
Exhibit 09: Pipeline landscape based on number of molecules 2016
Exhibit 10: HD: Key clinical trials
Exhibit 11: Segmentation of global HD therapeutics market by drug-class
Exhibit 12: Global HD therapeutics market share by drug-class
Exhibit 13: Antidopaminergics used in HD
Exhibit 14: Uses and side-effects of antidopaminergics
Exhibit 15: Global HD therapeutics market by antidopaminergics 2016-2021 ($ millions)
Exhibit 16: Pharmacologic approach for the treatment of chorea
Exhibit 17: Anticonvulsants used in HD
Exhibit 18: Uses and side-effects of anticonvulsants
Exhibit 19: Global HD therapeutics market by anticonvulsants 2016-2021 ($ millions)
Exhibit 20: Antipsychotics used in HD
Exhibit 21: Uses and side-effects of antipsychotics
Exhibit 22: Global HD therapeutics market by antipsychotics 2016-2021 ($ millions)
Exhibit 23: Symptoms of depression associated with HD
Exhibit 24: Global HD therapeutics market by antidepressants 2016-2021 ($ millions)
Exhibit 25: Symptoms of mania associated with HD
Exhibit 26: Global HD therapeutics market share by geography 2016 and 2021
Exhibit 27: Global HD therapeutics market revenue by geography 2016-2021
Exhibit 28: Global HD therapeutics market share by geography 2016-2021
Exhibit 29: HD therapeutics market scenario in different geographies
Exhibit 30: Market scenario in Americas
Exhibit 31: HD therapeutics market in Americas 2016-2021 ($ millions)
Exhibit 32: Market scenario in EMEA
Exhibit 33: HD therapeutics market in EMEA 2016-2021 ($ millions)
Exhibit 34: Market scenario in APAC
Exhibit 35: HD therapeutics market in APAC 2016-2021 ($ millions)
Exhibit 36: Planned clinical trials of iPS cell-based therapies
Exhibit 37: Competitive structure analysis of global HD therapeutics market 2016
Exhibit 38: F. Hoffmann-La Roche: Key highlights
Exhibit 39: F. Hoffmann-La Roche: Strength assessment
Exhibit 40: F. Hoffmann-La Roche: Strategy assessment
Exhibit 41: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 42: H. Lundbeck: Key highlights
Exhibit 43: H. Lundbeck: Strength assessment
Exhibit 44: H. Lundbeck: Strategy assessment
Exhibit 45: H. Lundbeck: Opportunity assessment
Exhibit 46: Prana Biotechnology: Key highlights
Exhibit 47: Prana Biotechnology: Strength assessment
Exhibit 48: Prana Biotechnology: Strategy assessment
Exhibit 49: Prana Biotechnology: Opportunity assessment
Exhibit 50: Teva Pharmaceuticals: Key highlights
Exhibit 51: Teva Pharmaceuticals: Strength assessment
Exhibit 52: Teva Pharmaceuticals: Strategy assessment
Exhibit 53: Teva Pharmaceuticals: Opportunity assessment



【掲載企業】

F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology, and Teva Pharmaceutical Industries.

Other Prominent Vendors in the market are: Intellect Neurosciences, Horizon Pharma, Sangamo Therapeutics, and Vertex Pharmaceuticals.


【資料のキーワード】

ハンチントン病、ハンチントン病治療薬

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[ハンチントン病治療薬の世界市場] (Global Huntington's Disease Therapeutics Market 2017-2021 / IRTNTR14144)販売に関する免責事項
[ハンチントン病治療薬の世界市場] (Global Huntington's Disease Therapeutics Market 2017-2021 / IRTNTR14144)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆